The Saudi Food and Drug Authority (SFDA) advises that ginseng (scientifically known as Panax Ginseng), used in alternative medicine as a general tonic to enhance energy levels and mitigate stress, should be used with caution. High-dose consumption may result in side effects such as insomnia and high blood pressure. Furthermore, pregnant and lactating women are advised to avoid ginseng due to a lack of safety data.

H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), recently conducted an inspection tour of the Authority’s Eastern Province branch, visiting several affiliated facilities.

The Saudi Food and Drug Authority (SFDA) held a workshop at its headquarters in Riyadh entitled “Consultative Sessions for Registering, Advertising, and Promoting Food, Feed, and Cosmetic Products.” The workshop, presented by several specialists from the SFDA, highlighted the mechanisms and procedures for registering, advertising, and promoting food, feed, and cosmetic products.

The Saudi Food and Drug Authority (SFDA) has intensified its field visits to food factories and distribution centers across various cities and regions of Saudi Arabia. This initiative aims to ensure the availability of necessary licenses, verify the existence and effectiveness of the Hazard Analysis Critical Control Point (HACCP) system, and confirm the presence of an effective tracking system.

His Excellency the CEO of the Saudi Food and Drug Authority (SFDA), Prof. Hisham S. Aljadhey, visited several food factories and facilities in the Makkah region.

The Saudi Food and Drug Authority (SFDA) seized 571 unlicensed facilities engaged in the manufacture and storage of food, medicines, and medical devices in the regions of Makkah and Madinah, referring the violating establishments to the competent authorities for legal action.

The SFDA explained that it conducted 3,676 inspection visits to the facilities under its supervision during intensive supervisory tours as part of its role during the Hajj season, ensuring the safety of food, medicines, and medical products.

The Saudi Food and Drug Authority (SFDA) detected 187 violating facilities and 277 types of products during 1,959 monitoring and inspection tours conducted across all regions of the Kingdom in May 2024.

The Saudi Food and Drug Authority (SFDA) has levied a fine of 500,000 SAR on a facility in the Qassim region for manipulating data related to a type of fish that is banned from importation into the Kingdom of Saudi Arabia.